One year experience with fast track algorithm in patients with refractory out-of-hospital cardiac arrest.


Journal

Resuscitation
ISSN: 1873-1570
Titre abrégé: Resuscitation
Pays: Ireland
ID NLM: 0332173

Informations de publication

Date de publication:
11 2019
Historique:
received: 11 02 2019
revised: 01 07 2019
accepted: 31 07 2019
pubmed: 12 8 2019
medline: 2 10 2020
entrez: 12 8 2019
Statut: ppublish

Résumé

Overall prognosis in patients with out-of-hospital cardiac arrest (OHCA) remains poor, especially when return of spontaneous circulation (ROSC) cannot be achieved at the scene. It is unclear if rapid transport to the hospital with ongoing cardiopulmonary resuscitation (CPR) improves outcome in patients with refractory OHCA (rOHCA). The aim of this study was to evaluate the effect of a novel fast track algorithm (FTA) in patients with rOHCA. This prospective single-center study analysed outcome in rOHCA patients treated with FTA. Historical patients before FTA-implementation served as controls. rOHCA was defined as: persistent shockable rhythm after three shocks and 300mg of amiodarone or persistent non-shockable rhythm and continuous CPR for 10min without ROSC after exclusion of treatable arrest causes. 110 consecutive patients with rOHCA (mean age 56±14 years) were included. 40 patients (36%) were treated with FTA, 70 patients (64%) served as historical controls. Pre-hospital time was significantly shorter after FTA implementation (69±18 vs. 79±24min, p=0.02). Favourable neurological outcome (defined as cerebral performance categories Score 1 or 2) was significantly more frequent in FTA patients (27.5% vs. 11.4%, p=0.038). FTA-implementation showed a trend towards improved mortality (70.0% vs. 82.9%, p=0.151). Extracorporeal Life Support was similar between the two groups. Our study suggests that a rapid transport algorithm with ongoing CPR is feasible, improves neurological outcome and may improve survival in carefully selected patients with rOHCA.

Sections du résumé

BACKGROUND
Overall prognosis in patients with out-of-hospital cardiac arrest (OHCA) remains poor, especially when return of spontaneous circulation (ROSC) cannot be achieved at the scene. It is unclear if rapid transport to the hospital with ongoing cardiopulmonary resuscitation (CPR) improves outcome in patients with refractory OHCA (rOHCA). The aim of this study was to evaluate the effect of a novel fast track algorithm (FTA) in patients with rOHCA.
METHODS
This prospective single-center study analysed outcome in rOHCA patients treated with FTA. Historical patients before FTA-implementation served as controls. rOHCA was defined as: persistent shockable rhythm after three shocks and 300mg of amiodarone or persistent non-shockable rhythm and continuous CPR for 10min without ROSC after exclusion of treatable arrest causes.
RESULTS
110 consecutive patients with rOHCA (mean age 56±14 years) were included. 40 patients (36%) were treated with FTA, 70 patients (64%) served as historical controls. Pre-hospital time was significantly shorter after FTA implementation (69±18 vs. 79±24min, p=0.02). Favourable neurological outcome (defined as cerebral performance categories Score 1 or 2) was significantly more frequent in FTA patients (27.5% vs. 11.4%, p=0.038). FTA-implementation showed a trend towards improved mortality (70.0% vs. 82.9%, p=0.151). Extracorporeal Life Support was similar between the two groups.
CONCLUSION
Our study suggests that a rapid transport algorithm with ongoing CPR is feasible, improves neurological outcome and may improve survival in carefully selected patients with rOHCA.

Identifiants

pubmed: 31401135
pii: S0300-9572(19)30562-3
doi: 10.1016/j.resuscitation.2019.07.035
pii:
doi:

Substances chimiques

Anti-Arrhythmia Agents 0
Amiodarone N3RQ532IUT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-165

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Christoph Adler (C)

Department of Internal Medicine III, Division of Cardiology, Pneumology, Angiology and Intensive Care, University of Cologne, Cologne, Germany; Department of Emergency Medicine, Fire Department City of Cologne, Cologne, Germany. Electronic address: Christoph.adler@uk-koeln.de.

Christian Paul (C)

Department of Emergency Medicine, Fire Department City of Cologne, Cologne, Germany.

Guido Michels (G)

Department of Internal Medicine III, Division of Cardiology, Pneumology, Angiology and Intensive Care, University of Cologne, Cologne, Germany.

Roman Pfister (R)

Department of Internal Medicine III, Division of Cardiology, Pneumology, Angiology and Intensive Care, University of Cologne, Cologne, Germany.

Anton Sabashnikov (A)

Department of Cardiothoracic Surgery, Heart Center of the University of Cologne, Cologne, Germany.

Jochen Hinkelbein (J)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital Cologne, Cologne, Germany.

Simon Braumann (S)

Department of Internal Medicine III, Division of Cardiology, Pneumology, Angiology and Intensive Care, University of Cologne, Cologne, Germany.

Llija Djordjevic (L)

Department of Cardiothoracic Surgery, Heart Center of the University of Cologne, Cologne, Germany.

Ralf Blomeyer (R)

Department of Emergency Medicine, Fire Department City of Cologne, Cologne, Germany.

Andrea Krings (A)

Department of Emergency Medicine, Fire Department City of Cologne, Cologne, Germany.

Bernd W Böttiger (BW)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital Cologne, Cologne, Germany.

Stephan Baldus (S)

Department of Internal Medicine III, Division of Cardiology, Pneumology, Angiology and Intensive Care, University of Cologne, Cologne, Germany.

Robert Stangl (R)

Department of Emergency Medicine, Fire Department City of Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH